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It  was  shown  previously  that  an  antigen-antibody  reaction  induced  in 
guinea pig  tissues  or serum  causes  the  activation  of the  enzyme precursor 
profibrinolysin (1, 2). These observations were confirmed by Geiger (3) while 
yon Euler and Heller (4) and Jemski, Flick, and Stinebring (5) were unable to 
duplicate  them.  The present paper  reports further observations on protease 
activation both by antlgen-antibody reaction and by "anaphylactoid" agents 
and attempts to explain the discrepancies between results published by differ- 
ent  workers.  Observations  are  also  reported  suggesting  that  profibrinolysin 
activation requires  the intervention  of a  kinase  system strikingly similar  to 
serum  complement. 
Methods 
Profibrinolysin Acli~ion.--As described in detail previously  (2), the enzyme precursor 
present  in guinea pig serum is activated  by mixing a certain amount of serum (usually 0.1 
or 0.2 ml.) with the activating agent.  After 3 minutes'  contact,  with constant shAlrlng, the 
mixture is diluted  twentflold with distilled water  and the PH adjusted  to 5.2 with  an 0.2 
per cent solution of acetic acid. The precipitate  formed is separated  by centrifugation  and 
redimolved in buffered saline (0.15 v phosphate in 0.15 K NaC1, pH 7.4). In the control sam- 
ples, saline is added to serum and the mixture treated as described above. 
F_aLimation of Fibrinolyti¢ Adivlty.--The presence of active protease  in  the euglobulin 
fraction is detected  by estimating fibrinolytic activity.  The method used in previous studies 
(1, 2) was based on the digestion of fibrinogen and estimation of the remaining flbrinogen by 
determining its dotting time after addition  of thrombin.  The technique used in the present 
investigation is also based on the digestion of fibrinogen, but this is determined with greater 
accuracy by measuring the ultraviolet absorption (at k  ~  280 m/~) of the fraction of flbrinogen 
rendered incoagulable by the action of fibrinolysln. 
The technique is an adaptation of the procedure described by Kunitz (6) for determination 
of tryptic activity.  The details have been given elsewhere (7) and only the main points will 
be mentioned here. The solution obtained after activation  of 0.1 or 0.2 ml. of serum is made 
up to 3.7 ml. with buffered saline (pH 7.4), mixed with 2 ml. of a 0.2 per cent fibrinogen  i 
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solution and placed for 20 minutes in a water-bath at 37.5*C. Mter this interval, 0.3 ml. of 
a solution of thrombin  ~ (containing 325 units per mL) is added to clot the remaining fibrinogen. 
Mter further incubation of 30 minutes the solution is filtered and the filtrate read on the 
Beckman spectrophotometer,  Readings are made against appropriate blanks to correct for 
the  ultraviolet absorption  of all the  reagents. 
The optical density readings can be converted into milligrams of fibrinogen hydrolyzed 
and these are, as seen in Table I, directly proportional to enzyme concentration. As routine, 
however, it seemed more appropriate  to express the results in units  defined according to 
Kunitz  (6): one unit of fibrinolysin is the amount of enzyme which, under the conditions 
TABLE I 
Comparison be~e~n the Action of Borineand Guinea Pig Fibrinol sins on Fibrinog~a  and Fibrin 
Guinea pig euglobulin* 
Bovine fibrinolysin 
0.05 ml. 
0.1 
0.15 
0.2 
0.3 
0.5 
0.1 rag. 
0.2 
0.3 
0.4 
0.5 
0.75 
1.0 
Amount digested 
Fibrinogea  Fibrin 
rag.  rag. 
0.95 
1.8 
2,75 
3.25  0.35 
--  0.55 
--  0.85 
0.75 
1.6 
2.45 
3.2  0.3 
--  0.4 
--  0.6 
--  0.75 
Fibrinogen digestion was done according to the procedure described in the text. For fibrin 
digestion, fibrinogen was clotted with thrombin and incubated for 30 minutes before addi- 
tion of the enzyme. In all samples the initial fibrinogen concentration was 4 rag. 
* Serum from guinea pigs sensitized against rabbit serum was activated by the specific 
antigen. 
just described, gives rise to an increase of one optical density unit per minute. The fibrinolysin 
content of the samples is more conveniently expressed  in 10  -a units. These will be referred to 
in  the  text  as  "units." 
The control samples (serum +  saline)  nearly always showed a certain amount of fibrino- 
lyric activity (see Table II). This "spontaneous" activation seemed to occur when the blood 
sample had been contaminated with fluid from traumatized tissues or in sera which had been 
allowed to stand  for several days before the experiment.  Sera showing a  spontaneous  ac- 
tivity over 40 units per ml. were discarded for reasons which will be discussed  below. In all 
tables the number of units listed as resulting from the activation of profibrinolysin represent 
the excess over the spontaneous activity of the corresponding controls. 
The protease activity appearing in the sera submitted to various treatments is attributed 
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in this study to the enzyme termed fibrinolysin or plasmin. These terms, used interchange- 
ably, probably designate a mixture of enzymes. For example, Mullertz (8) described recently 
under the name of plasmin a protease which attacks fibrin but not fibrinogen. Table I shows 
that the protease described in the present report has a  higher affinity for fibrinogen than 
for fibrin. It is aLso seen that its respective a~nity for these substrates closely resembles that 
of a  bovine fibrinolysin obtained by chloroform  treatment of plasma  (9).  s 
Immunolog~al Teclmique.s.--Guinea  pigs were sensitized to egg albumin by a single sub- 
cutaneous injection of the antigen  a (0.5 ml. of a  1 per cent solution). Sensitization against 
rabbit serum was induced by intracardial injection of 0.5 ml. The animals were bled after a 
stated interval by heart puncture. The guinea pig serum was used either immediately after 
separation or after a few days' storage at --20°C. 
Antibody nitrogen was  determined according to  the  technique described  by Germuth 
et a/. (10) using the ultraviolet absorption of the redissolved antigen-antibody complex. Frac- 
tionation of complement and complement titration were  done according to the techniques 
described by Kabat and Mayer (11). 
RESULTS 
Profibrinolysin Activation by Antigen-Antibody Reaction.--In  view  of  the 
contradictory results,  mentioned above, published by certain workers  (3--5) 
experiments  were  performed  to  determine  the  precise  conditions  required 
for  profibrinolysin activation.  Experiments  similar  to  those  previously  re- 
ported  (2) were repeated using a  more accurate technique. 
Each serum was divided into three samples,  usually of 0.2  ml. each.  Samples A and B 
were mixed with 0.2 ml. of saline and sample C with 0.2 ml. of a 0.2 or 0.5 per cent.solution 
of egg albumin. After 3 minutes' contact, the mixtures were diluted to 8 ml. with distilled water 
and the pH adjusted to 5.2  as described above. The resulting euglobulin precipitate was 
centrifuged off and redissolved  in 3.7 ml. buffered saline. 2 ml. of a 0.2 per cent solution of 
fibrinogen were added to samples B and C and the same volume of buffered saline was added 
to sample A. After 20 minutes' incubation at 37.5°C., 0.3 ml. of thrombin was added to all 
samples and after a further incubation of 30 minutes the solutions were faltered. The ultra- 
violet absorption of the filtrates was read at 280 rap. 
The reading of sample B against A, corrected by subtracting the absorption of a fibrinogen- 
thrombin blank, gives the spontaneous fibrinolytic activity. The reading of sample C against 
B, corrected by subtracting the absorption of an egg albumin blank (which had been treated 
by dilution and acidification like the serum samples), gives the fibrinolytic activity produced 
by the antigen-antibody reaction. Optical densities were  converted into units according to 
the definition given in the preceding section. 
Since under the conditions of the method, activities above 25 units cannot be measured in 
a given sample, most of the sera were also tested at 0.1 ml. In this case the amount of antigen 
added was reduced by half. 
The results of these experiments are expressed  in Table II in terms of  10  -4 
units of fibrinolytic activity per ml. of guinea pig serum. It is seen that spon- 
taneous activation occurs in most sera (15.0 4- 11.0 units per ml. of serum) but 
under  the  influence of  the  antigen-antibody reaction  fibrinolytic activity  is 
significantly increased.  Addition of  2  mg.  of egg albumin to  the homologous 
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TABLE H 
ActhaJion of Proflbrinolysin in  Guinea Pig  Ant&era by Addition  of Homologous Antigen 
Fibrinolysin  10  "~ U/ml. after addition  of 
Serum 
Anti-egg albumin 
gg  ~g 
~c  ~c 
~c  ~C 
Anti-egg albumin 
C~  ¢~ 
dg  c~ 
¢~  cc 
Anti-rabbit serum 
Cl  ~¢ 
|~  gg 
~g  t~ 
g¢  ¢¢ 
Antigen 
Egg albumin 
(2 mg./ml, serum) 
LC  cc  cc 
CC  c¢  ¢C 
cc  cc  ¢~ 
Egg albumin 
(5 mg./ml, serum) 
C~  ~  cc 
cc  c¢  ~c 
Rabbit serum 
(0.04 ml./ml, serum)I[ 
cc  lc 
c¢  cc 
Cc  cc 
SaUne 
21.00 
16.25 
20.00 
12.50 
17.00 
20.00 
13.00 
0 
38.50 
Antigen 
132.50 
127.50 
137.50 
95.00 
129.75 
25.00 
125.00 
87.50* 
149.50~ 
17.64-10.1§  112.14-38.2§ 
26.00 
20.50 
0 
29.00 
80.00 
92.50 
55.00" 
112.50~ 
18.94-12.8§  85.04-24.1§ 
12.00 
0 
6.50 
22.50 
0 
82.50 
95.00 
115.00 
102.50 
67.25 
8.2q-9.4§  92.54-18.4§ 
Normal 
18.00 
0 
27.50 
7.25 
18.00 
2.00 
7.50 
0 
2.75 
5.50 
Egg albumin 
(2 mg./ml, serum) 
Cc  cg  ~¢ 
cg  Cg  ~g 
gg  g~  ~g 
¢¢  g¢  g¢ 
14.15q-10.7§  3.54-3.0§ 
* Pooled serum A (see text). 
:~ Pooled serum B  (see text). 
§ Mean and standard deviation. 
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antisera produced 112.1  4- 38.2 units, while 5 rag. of the same antigen added 
to  the  same serum produced  only 85.0  4-  24.1  units per ml. When  another 
antigen,  rabbit serum, was used,  similar results were obtained  (92.5  4-  18.4 
units per ml.). When however, normal guinea pig sera were treated with egg 
albumin only an insignificant increase in proteolytic activity (3.5 4- 3.0 units 
per ml.) was observed. 
As  stated  above,  results  obtained  with  sera  showing  high  spontaneous 
activity (over 40 units per ml.) were discarded and are not listed in Table II. 
Such  sera do not undergo  further activation when  treated with  the antigen. 
Six samples with an average spontaneous activity of 85.5 4- 27.0 units showed 
an additional activity of 11.5 4- 10.5 units per ml. when mixed with 2 mg. per 
ml. of egg albumin. The reason for this may be either that all the available 
profibrinolysin of these sera has already been converted into fibrinolysin or, 
more probably, that  free fibrinolysin destroys a  kinase,  as will be discussed 
below (12). 
To  show  whether  profibrinolysin  activation  was  caused  by  an  antigen- 
antibody reaction the following experiment was carried out. 
Antibody concentration was determined in two pooled samples of guinea pig serum. Serum 
A was collected 4 weeks after sensitization and its antibody N was 0.03 rag. per ml. Serum B 
was collected from the same guinea pigs 1 week later; its antibody N was 0.083 rag. per ml. 
The antibody content of these sera was also tested by passive anaphylaxis. Four guinea pigs 
were injected with each of the serum samples (0.5 ml. given intracardially to guinea pigs with 
a mean weight of 300 gin.). 48 hours later, shock was elicited by intracardial injection of 0.5 
ml. of a 1 per cent solution of egg albumin. With serum A, two guinea pigs showed signs of 
shock  but  none died. With  serum  B,  three  guinea  pigs  died and  autopsy  showed 
typical anaphylactic lung changes. It is seen in Table II that serum B produced higher prote- 
olytic activity  than  serum A. 
The  results  shown  in  Table  II suggest  that  increased  concentrations  of 
antigen do not necessarily produce higher fibrinolytic activity. This was tested 
in a  series of experiments in which a  pooled serum sample from guinea pigs 
sensitized  to egg albumin was mixed with  varying amounts  of the antigen. 
The  results  summarized  in  Table  III  show  that  profibrinolysin activation 
first increases with antigen concentration but,  after having reached an opti- 
mum, declines, and with high enough concentrations falls to zero. 
Proflbrinolysin Activation by Anapkylactoid  Agents.--It  was  shown  previ- 
ously that proteolytic activity can be induced  in normal guinea  pig sera by 
addition  of peptone  and  certain  high  molecular  weight  carbohydrates  (2). 
These substances have one common property: when injected into animals, they 
can  reproduce  some of the  symptoms and  tissue  changes  observed in  ana- 
phylaxis. The manifestations thus produced are often called "anaphylactoid" 
and  the  substances which  cause  them may  be designated  as  anaphylactoid 
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Peptone  activation was  repeated using the  spectrophotometric  technique 
for the estimation of fibrinolytic activity. Peptone  s (20 mg. per ml. of serum) 
was  added  to fourteen  individual  guinea  pig serum  samples.  No  activation 
occurred  in  three  sera  but  the  remaining  eleven  showed  high  proteolytic 
activity. The mean value was 110.1  -4- 66.9 units per ml. of serum. 
A  number of substances have been mentioned in recent literature as being 
able to produce anaphylactoid phenomena. Some of these are polymers, such 
as polyoxyethylene sorbitan monolaurate (tween 20)  (13) and a mixture of the 
di-,  tri-  and  tetramers  of p-methoxyphenethyl-methylamine known  as sub- 
stance 48/80  (14).  The same effect is exerted by certain alkaloids of opium 
(15)  and curare  (16).  Even simple amines, like octylamine, decylamine (17), 
and octadecylamine (18) were shown to produce anaphylactoid manifestations. 
TABLE Ill 
Influenc~ of Antigen Concentration on Profibrinolysin Activation 
Egg albumin/ml,  guinea pig serum  Fibrinolysin 10s U/mL sen~m 
mgJml. 
0.1 
0.5 
1.0 
2.5 
5.0 
10.0 
25.0 
50.0 
32.5 
87.5 
145.00 
152.50 
147.50 
107.50 
57.50 
0 
Guinea pigs were bled 6 weeks after sensitizing injection. 
Some of these agents were tested for profibrinolysin activation and the results 
of these  tests are shown in Table IV.  It is seen that  tween  20, 5 morphine, 
octylamine,  6 octadecylamine  7 and  48/80, s  all  activate  profibrinolysin  to  a 
varying extent. It should be noted that some of these agents, as in the case of 
antigen, also cause less activation at concentrations above the optimum level. 
Serofibrirwkinase  and  Coraplement.--In  a  previous  report  attention  was 
called  to  the  fact  that  activation  of  profibrinolysin  by  antigen-antibody 
reaction  or  anaphylactoid  agents  does  not  seem  to  result  from  the  direct 
action of these activators on the enzyme precursor (2). It was observed that 
addition  of peptone to partially purified profibrinolysin fails to bring about 
activation.  It was  also  reported  that  serum previously heated  to  56°C.  for 
4 Neopeptone, Difeo Laboratories, Detroit. 
5 Batch  225 B, by courtesy of Atlas Powder Co. 
6 2-Amino-n-octane, Eastman  Kodak  Co., Rochester, New  York. 
7 Kindly supplied by Dr. F.  C. McInfire, Abbott  Laboratories, North  Chicago. 
8 Kindly supplied by Dr.  F.  C. Macintosh,  McGill University, Montreal. G. UNGAR~ E. DAMGAARD~  AND F, P. HUMMEL 
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Pro~brinolysin Acl~ration in Guinea Pig Serum by Anaphylactoid Agents 
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Agent/ml. serum  Fibrinolysin I0-=  U/ml. serum 
Tween 20  0.2/A. 
0.6 
0.8 
tt 
ct 
tt 
tt 
tt 
tt 
tt 
8.30 
76.50 
120.00 
100.25 
85.00 
55.00 
90.00 
112.50 
50.25 
125.50 
Morphine sulfate  0.75 rag. 
1.1 
1.3 
1.5 
1.75 
2.2 
3.0 
Octylamine  0.25 rag. 
tt 
tc 
tt 
Octadecylamine  0.07 nag. 
O. 14 
ct 
0.28 
tt 
c¢ 
48/80  0.2 rag. 
1 
1.5 
2.0 
5.0 
92.50 
87.50 
93.50 
92.75 
97.50 
51.25 
35.00 
35.00 
105.50 
97.25 
85.25 
115.50 
49.00 
58.00 
63.00 
77.00 
26.00 
36.00 
37.50 
60.00 
125.00 
55.00 
45.00 
27.50 
30  minutes  cannot  be  activated  by  peptone.  Under  both  these  conditions 
streptokinase  (an  activator  produced  by  certain  strains  of  streptococci)  is 
still  capable of activating profibrinolysin.  It was therefore assumed that the 
anaphylactic or anaphylactoid type of activation,  as opposed to the strepto- 
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fresh guinea pig serum. This kinase system was given the name of serofibrino- 
kinase. 
Experiments were carried out first to determine whether the anaphylactoid 
agents listed above as profibrinolysin activators also acted through serofibrino- 
kinase.  Table  V  shows  that  addition  of  these  agents  to  serum  previously 
heated to 56°C. for 30 minutes or to the euglobulin fraction of serum did not 
result in any significant activation of profibrinolysin, as compared with the 
effect of these agents on whole, fresh serum. The fact that streptokinase  0 is 
active under all conditions investigated is evidence that profibrinolysin was 
not destroyed by heating or precipitation. All anaphylactoid agents investi- 
gated seem therefore to act through serofibrinokinase. 
TABLE  V 
Comparison of the Effects of Profibrinolysin Activators Added to Fresh Serum, Heated Serum, 
or to Globulin Fraction 
Activator]ml.  serum 
Egg albumin 2 rag.* 
Rabbit serum 0,04 ml.* 
Peptone 20 nag. 
Tween 20 0.8 ~l. 
Morphine sulfate 1.5 rag. 
Octylsmine 0.25 rag. 
48/80 1 rag. 
Streptokinase 2.5 nag. 
Fibrinolysln 101 U/ml. serum 
Activator  added to 
Fresh serum  Heated serum 
137.50  40.00 
95.00  25.00 
180.00  27.50 
120.00  12.50 
97.50  0 
105.50  35.00 
125.00  17.50 
125.00  95.00 
Globulin 
15.00 
2.50 
25.00 
0 
5.00 
12.50 
7.25 
140.00 
* Added to sensitized guinea pig serum. 
Since serofibrinokinase was not present in the euglobulin fraction of serum, 
it  was  first  assumed  that  it  must  have  remained  in  the  supernatant.  No 
significant  activation  was  observed,  however,  when  the  supernatant  of an 
activated serum preparation was added to normal euglobulin or to whole fresh 
serum.  Negative  results  were  also  obtained  when  the  euglobulin  was  first 
precipitated,  the  activating  agent  added  to  the  supernatant,  and  the  two 
fractions mixed again. 
From these observations the conclusion was reached that under the condi- 
tions of the test serofibrinokinase occurred only in whole, fresh serum. Results 
shown in Table VI supply evidence that the addition of fresh normal serum 
to  heated  antibody-containing  serum  increases  profibrinolysin  activation, 
presumably by increasing serofibrinokinase concentration. There is, however, 
an objection to this interpretation since the fresh serum, besides serofibrino- 
9 Kindly supplied by Dr. B. W. Carey, Lederle Laboratories, Pearl River, New York. G.  UNGAR,  E.  DAMGAARD,  AND  F.  P.  HUMMEL  299 
kinase, also contains profibrinolysin and this contributes to the final amount 
of  fibrinolysin  detected.  Completely  satisfactory  results  could  be  obtained 
only by separating the kinase from the proenzyme. 
Since  fresh guinea pig serum is known to contain  a  system which  can be 
brought into action by the antigen-antibody reaction, an attempt was made 
to  determine  whether  this  system,  complement,  was in  any way related  to 
TABLE VI 
Action of Fresh Non-Sensltized Guinea Pig Serum on Profibrinolysin Actg~alion by 
Antig~-Antibody Reaction 
Fresh immune serum 
0.1 
Heated immune serum  Fresh normal serum 
m 
0.1 
0.1 
0.1 
0.1 
0.1 
B 
0.01 
0.05 
0.1 
0.2 
0.2 
Fibrinolysin I0-* U/mL 
serum 
102.5 
20.0 
62.5 
65.0 
92.5 
150.0 
12.5 
The antigen was egg albumin 2 mg./ml, of serum. 
TABLE VII 
Fr~tionathm  of Cor,  q~y,a  and Proftbzinolysin Acti~on 
Fibrinolysln 10"-I  U/ml. serum 
Activator  Whole serum 
Yeast-treated  NHt-treated  Reconstituted" 
None  12.5  1.5  6.5  -- 
Egg albumin,~ 2 mg./ml.  95.0  12.5  25.0  85.0 
Tween 20, 0.8 ~L/ml.  85.0  17.5  16.5  82.5 
Streptokinase, 2.5 mg./mL  100.0  93.5  87.5  -- 
Complement titer§  80-120  0-20  0  80-100 
* Reconstituted by mixing equal parts of yeast-treated  and 1VHrtreated samples. 
Added to guinea pig serum sensitized to egg albumin. 
§ 50 per cent hemolysis method. 
serofibrinokinase. It is known that complement consists of at least four com- 
ponents and that the loss of any one of these components results in inactiva- 
tion. In a  first series of experiments profibrinolysin activation was studied in 
sera in which the third and fourth components of complement were destroyed. 
It is seen in Table VII that treatment of serum with yeast (which adsorbs the 
third component) or with ammonia (which inactivates the fourth component) 
results  in  inhibition  of profibrinolysin activation by the antigen  or an ana- 
phylactoid agent. The table shows that when the two deficient serum fractions 300  FIBRINOLYSIS AND  COMPLEMENT 
are mixed  together,  fibrinokinase activity,  as  well  as  complement  function, 
again became manifest. It is also seen that activation by streptokinase is not 
affected significantly by the inactivation of complement. 
In  other  experiments,  complement  was  fixed  with  an  antigen-antibody 
system and  fibrinokinase activity tested  in the supernatant. 
TABLE VIII 
Complemenl Fixation and Profibrinolysin Actiration 
Fibrinolysin  10-1 U/ml. serum 
Activator 
Non*sensitized  Sensitized 
red cells  red cells 
None  27.5  15,0 
Egg albumin,* 2 mg./ml.  102.5  35.5 
Tween 20, 0.8 ~l./mL  105.0  15.5 
Streptokinase, 2.5 mg./mL  105.0  125.0 
Complement titer~  90  10-15 
* Added to guinea pig serum sensitized to egg albumin. 
50% hemolysis method. 
Since comparatively large  amounts of serum were  required,  an excess of both antigen 
(sheep blood cells) and antibody (rabbit anti-sheep hemolysin) had to be used. To 1 mL of a 
20 per cent sheep cell suspension 1 ml. of a 1/100 dilution of hemolysin I° and 0.2 ml. of guinea 
pig serum were added and the mixture kept at 2°C. for 45 minutes.  After this interval, the 
samples were centrifuged  and the superuatant submitted to the activating agents according 
to the technique  described above. Control samples were set up at the same time, containing 
all the reagents except hemolysin so that the sheep cells were not sensitized. Table VIII shows 
that, when complement was fixed by the sheep cell-hemolysin system, profibrinolysin activa- 
tion occurred only with streptokinase and not with the specific antigen or tween 20. In the 
control samples in which complement was not fixed, activation occurred with all three agents. 
From the results of these experiments it can be concluded that serofibrino- 
kinase activity disappears from sera in which complement is split, fixed or, as 
seen in Table V above, inactivated by heating. It was also observed that, when 
serum  is  treated  with  an  anticomplementary  substance  such  as  Congo  red 
(19),  profibrinolysin activation  is  inhibited.  Another  compound,  polylysine 
(a 31-met of L-lysine),  n  was first found to inhibit profibrinolysin conversion. 
When tested on a  hemolytic system, polylysine also proved to be an inhibitor 
of complement. 
DISCUSSION 
The observations just described can probably explain some of the contradic- 
tory results published on protease activation by the antigen-antibody reaction. 
to Bacto anfisheep  hemolysin,  Difco Laboratories, Detroit. 
n Kindly supplied by Dr. E~ Katchalski, Weizmann Institute of Science, Jerusalem, Israel. G.  UN'GAR,  E.  DAMGAARD,  AND  P.  P.  HUMMEL  301 
It is  seen  that this activation takes place only when whole serum is  used. 
This explains  the negative results obtained by workers  using the euglobnlin 
fraction of serum or any other partially purified preparation (4, 5). The present 
study shows  that maximum activation occurs  at an optimal ratio between 
antibody and antigen; addition of too little or too much antigen to serum 
produces  degrees of activation too small to be detected by most methods. It 
is also shown above that sera with high spontaneous activity cannot be further 
activated by the antigen. This invalidates the negative results observed  in 
series in which high spontaneous activity was a  regular occurrence  (5). De- 
velopment of spontaneous fibrinolytic activity seems  to  depend on certain 
details of handling the blood samples;  technique of bleeding,  storage,  and 
probably other factors. A last cause of error is the absence of antibody from 
the sera used (5); negative results obtained with such sera confirm rather than 
contradict the assumption that profibrinolysin  activation is  caused  by the 
antigen-antibody reaction. 
The results indicate that profibHnolysin is activated in guinea pig serum by 
number of comparatively simple  chemical  compounds.  These compounds, 
like the antigen-antibody complex, have the ability to produce anaphylactic 
manifestations when injected into animals d  the appropriate species. These 
substances are also called "histamine liberators" (15) because they have the 
ability to release histamine from tissues  in d~o as well as in dtro.  There is 
reason  to believe that there is a  causal  link between the properties  of these 
substances:  they produce  anaphylactoid phenomena  because  they  release 
histamine and they release histamine because  they activate profibrinolysin. 
In a  series of experiments  conducted simultaneously with those reported in 
this paper  a  high correlation was  observed  between histamine release  and 
proteolysis when guinea pig lung slices were subjected to an antigen-antibody 
reaction or to anaphylactoid stimuli (20). All these results tend to confirm the 
view that activation of a proteolytic enzyme system occupies a key position in 
the chain of events leading to local and systemic allergic phenomena (21, 22). 
The exact identity d  this proteolytic enzyme system  can only be deter- 
mined by its isolation.  Fihrinolysin (or plasmin)  is a term which has come to 
designate several  different enzymes,  as shown by the example mentioned in 
the  section  on  Methods.  Whether  the  fibHnolysin  which  results  from the 
activation process dealt with in this paper is a unique protease or a mixture 
of several  enzymes is  as yet undecided. 
Activation of profibrinolysin  under the conditions described  above seems 
to require  the intervention of a kinase system. In all instances investigated, 
this kinase system behaves in a  way indistinguishable  from complement.  It 
would be meaningless  to say that serofibrinokinase  is identical with comple- 
ment  since  the  identity of complement itself is  but  vaguely defined.  The 
presence  of complement in serum can be detected because of its involvement 
in the antigen-antibody reaction. The present findings suggest, however, that 302  I~IBRINOLYSIS AND  COMPL]~M'ENT 
complement may also play a role in non-specific  reactions taking place in the 
absence of an antibody. They also indicate that  complement is required for 
the production of anaphylactoid phenomena as well as for true anaphylaxis. 
There are other indications  that  the fibrino]ytic system is somehow con- 
nected  with  complement.  Geiger  believes that  activation  by streptokinase 
also requires a "complement-like" factor (23). Pillemer a  al. have shown that 
fibrinolysin  inactivates  complement  (12).  The  latter  observation  explains 
perhaps the fact mentioned above that  sera with high spontaneous activity 
do not undergo further activation by the antigen-antibody reaction. 
Profibrinolysin and  serofibrinokinase  exist  in  normal  serum  side by side 
without any apparent interaction. The available evidence suggests that, under 
the  influence  of  the  activating  agents,  serofibrinokinase  undergoes  some 
change which renders it capable of reacting with profibrinolysin and convert- 
ing it into fibrinolysin.  The nature of this change is unknown. 
SUMMARY 
The activation of profibrinolysin in sensitized guinea pig serum when mixed in 
dtro with the homologous antigen was confirmed with a  more accurate and 
more reliable method than  the one previously used. A  study was made of 
some of  the  conditions  required  for obtaining  maximum  activation. 
Profibrinolysin activation  was also induced  in  normal  guinea  pig  serum 
by addition  of certain  "anaphylactoid"  agents  such  as peptone,  tween 20, 
morphine,  octylamine,  octadecylamine,  and  48/80. 
The  specific  antigen  and  the  anaphylactoid  agents  produce  activation 
only when added to whole,  fresh,  unheated serum. Profibrinolysin activation 
by these agents, as opposed to activation by streptokinase, seems to require 
the intervention  of a  kinase system (serofibrinokinase)  inactivated by frac- 
tionation of serum and by heating to 56°C. 
Whenever serum was submitted to treatments which caused fractionation, 
fixation or inhibition  of complement, serofibrinokinase was also inactivated. 
Under the conditions investigated  the behavior of this kinase was indistin- 
guishable from that of complement. 
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